Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1311 of 5804
-
Kidney shield? diabetes drug shows promise for teens
Disease control CompletedEffect of Sodium-Glucose Cotransporter (SGLT) 2 Inhibitors on Diabetic Nephropathy Progression in Adolescents with Type 1 Diabetes Mellitus
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Freeze your knee pain away? new cold injection trial aims to ease arthritis
Symptom relief OngoingThe goal of this clinical trial is to evaluate the effectiveness of Neural Ice for pain management associated with knee osteoarthritis in adults aged 22-80 years. Participants will attend study visits and complete subject diaries. Participants will be followed for 6 months after …
Phase: NA • Sponsor: Brixton Biosciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Less neck surgery may be just as safe for some thyroid cancers
Disease control Recruiting nowThis study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental group (selective neck dissection) or the control group (modified neck dissection), with LRFS as the pr…
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Can multiple myeloma treatment move out of the hospital? new study tests Home-Based dosing
Disease control Recruiting nowThis is a pilot study to develop an outpatient-based process for the administration of teclistamab for for relapsed/refractory multiple myeloma patients and to evaluate the burden on caregivers of patients receiving outpatient administration of teclistamab.
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Smaller stent, bigger hope: new TIPS technique aims to prevent brain fog
Disease control Recruiting nowTransjugular intrahepatic portosystemic shunt (TIPS) is a critical therapeutic approach for managing esophagogastric variceal bleeding and refractory ascites in decompensated cirrhosis patients. To date, hepatic encephalopathy (HE) remains one of the most common complications fol…
Phase: NA • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for kids with pouchitis: drug trial targets inflammation
Disease control Recruiting nowWhen some people have their large bowel removed, a surgeon can make a "pouch" from part of the small bowel to connect it to the back passage (anus). Pouchitis is when the pouch becomes inflamed (swollen) or infected. The main aim of this study is to find out if vedolizumab improv…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 26, 2026 19:09 UTC
-
New blood test could spot fetal chromosome issues weeks earlier
Diagnosis Recruiting nowDemonstrate the efficacy of an ultra-early, non-invasive prenatal diagnostic method adaptable to various genetic indications to detect fetal chromosomal abnormalities.
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New chemo formula aims to keep lung cancer away after surgery
Disease control Recruiting nowThis study evaluates the use of SMS001 in patients with lung cancer. SMS001 is a new form of drug Paclitaxel. Doctors want to decide an appropriate safe dose for SMS001 administration, and to see how well it works in treating lung cancer patients.
Phase: PHASE2 • Sponsor: ToLymph Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Experimental Alzheimer's drug aims to quiet Brain's toxic tau
Disease control Recruiting nowThis study will assess if drug (NIO752) reduces production of a protein, tau, by the brain. Normally tau maintains the internal skeleton of nerve cells. In Alzheimer's disease (AD) it builds up in the brain, causing damage. Abnormal tau proteins cling to each other forming 'tangl…
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could stem cell secretions protect hearing during implant surgery?
Disease control OngoingThe goal of this clinical trial is to assess the safety of intracochlear application of VSF1.01 for the reduction of cochlear implant surgery related trauma in patients with profound hearing loss with or without non-functional residual hearing in low frequencies and cochlear impl…
Phase: PHASE1, PHASE2 • Sponsor: Hannover Medical School • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Mindfulness over meds? new study tests stress reduction for black Women's heart health
Symptom relief Recruiting nowHigh blood pressure is a powerful risk factor for heart disease. Black women are more likely to have high blood pressure than white women or Hispanic women. Even when they are aware they have high blood pressure, many people struggle to keep their blood pressure controlled. Resea…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Could a headband device at home help save your sight?
Symptom relief Recruiting nowThe purpose of this study is to test the efficacy and feasibility of an intervention protocol for home-based repetitive transorbital alternating current stimulation (rtACS) for the treatment of visual impairment in people with optic neuropathy. The primary aims are to evaluate th…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
One shot for two viruses? new combo vaccine trial shows promise
⭐️ VACCINE ⭐️ CompletedStudy VBT00002 is planned to be a Phase 1/2, randomized, modified double-blind, active-controlled, multi-center study to be conducted in approximately 980 adults aged 50 years and older in the United States. The purpose of the study is to assess the safety and immunogenicity of r…
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
Smartphone mindfulness may offer Real-Time relief for dementia caregivers
Symptom relief Completed1. To determine an effective decision rule for delivering brief mindfulness prompts as a function of caregivers' real-time stress state, including whether prompt delivery affects subsequent stress and affect and whether this effect varies by stress state at the decision point. 2.…
Phase: NA • Sponsor: Education University of Hong Kong • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New study opens door for CAR t therapy in patients with kidney disease
Disease control Recruiting nowThis is a prospective, descriptive study designed to assess the feasibility of administering CAR T therapy among patients with moderate to severe renal impairment using dose adjusted lymphodepleting chemotherapy.
Phase: PHASE2 • Sponsor: Northside Hospital, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New combo therapy aims to keep lung cancer from returning after surgery
Disease control OngoingThe objective of this study is to explore the safety of alectinib in combination with chemotherapy in participants with resectable NSCLC. Cohort B1 is a phase II cohort that will assess the safety of alectinib in combination with up to four cycles of platinum-based chemotherapy i…
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New dressings aim to close stubborn wounds faster
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of hard-to-heal diabetic foot and venous leg ulcers.
Phase: NA • Sponsor: Integra LifeSciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New smart drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and anti-tumor activity of DAY301, a PTK7-directed antibody-drug conjugate (ADC) in participants with advanced or metastatic solid tumors. The study comprises of 2 phases: Phase 1a dose …
Phase: PHASE1 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New study aims to keep HIV patients on track after prison release
Disease control Recruiting nowThe overarching goal of this study is to implement a transition community adherence club strategy (Full-SPARCS) for HIV-positive individuals transitioning from correctional to community settings in South Africa. The investigators seek to provide actionable findings to inform poli…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New combo pill aims to simplify diabetes care
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of Madalena association in the treatment of type 2 diabetes mellitus.
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC